Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for TRD with Suicidal Ideation
NCT02094898Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Mayo Clinic. Started Sep 2014; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02094898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02094898.